nodes	percent_of_prediction	percent_of_DWPC	metapath
Toremifene—CYP1A1—Thalidomide—leprosy	0.337	0.374	CbGbCtD
Toremifene—CYP1A2—Thalidomide—leprosy	0.15	0.167	CbGbCtD
Toremifene—CYP1A2—Rifampicin—leprosy	0.146	0.162	CbGbCtD
Toremifene—ABCB1—Rifampicin—leprosy	0.127	0.142	CbGbCtD
Toremifene—CYP3A4—Rifampicin—leprosy	0.0763	0.0848	CbGbCtD
Toremifene—CYP3A4—Dapsone—leprosy	0.063	0.07	CbGbCtD
Toremifene—Thromboembolic event—Thalidomide—leprosy	0.00792	0.0785	CcSEcCtD
Toremifene—Foetor hepaticus—Thalidomide—leprosy	0.00376	0.0373	CcSEcCtD
Toremifene—Deep vein thrombosis—Thalidomide—leprosy	0.0035	0.0348	CcSEcCtD
Toremifene—Embolism—Thalidomide—leprosy	0.00332	0.033	CcSEcCtD
Toremifene—Liver disorder—Thalidomide—leprosy	0.00313	0.031	CcSEcCtD
Toremifene—Hypercalcaemia—Thalidomide—leprosy	0.00307	0.0304	CcSEcCtD
Toremifene—Thrombosis—Thalidomide—leprosy	0.00301	0.0299	CcSEcCtD
Toremifene—Musculoskeletal stiffness—Thalidomide—leprosy	0.00238	0.0236	CcSEcCtD
Toremifene—Skin discolouration—Thalidomide—leprosy	0.00236	0.0234	CcSEcCtD
Toremifene—Neuropathy peripheral—Dapsone—leprosy	0.00228	0.0227	CcSEcCtD
Toremifene—Coordination abnormal—Thalidomide—leprosy	0.00217	0.0215	CcSEcCtD
Toremifene—Pulmonary embolism—Thalidomide—leprosy	0.00213	0.0212	CcSEcCtD
Toremifene—Hepatocellular injury—Thalidomide—leprosy	0.00213	0.0212	CcSEcCtD
Toremifene—Dry eye—Thalidomide—leprosy	0.00197	0.0195	CcSEcCtD
Toremifene—Thrombophlebitis—Thalidomide—leprosy	0.00179	0.0177	CcSEcCtD
Toremifene—Vision blurred—Dapsone—leprosy	0.00172	0.017	CcSEcCtD
Toremifene—Vertigo—Dapsone—leprosy	0.00164	0.0162	CcSEcCtD
Toremifene—Arthritis—Thalidomide—leprosy	0.00159	0.0158	CcSEcCtD
Toremifene—Cardiac failure—Thalidomide—leprosy	0.00159	0.0157	CcSEcCtD
Toremifene—Lethargy—Thalidomide—leprosy	0.00158	0.0157	CcSEcCtD
Toremifene—Diplopia—Thalidomide—leprosy	0.00155	0.0154	CcSEcCtD
Toremifene—Affect lability—Thalidomide—leprosy	0.00152	0.0151	CcSEcCtD
Toremifene—Mood swings—Thalidomide—leprosy	0.00147	0.0145	CcSEcCtD
Toremifene—Ataxia—Thalidomide—leprosy	0.00146	0.0144	CcSEcCtD
Toremifene—Liver function test abnormal—Thalidomide—leprosy	0.00143	0.0142	CcSEcCtD
Toremifene—Breast disorder—Thalidomide—leprosy	0.0014	0.0139	CcSEcCtD
Toremifene—Insomnia—Dapsone—leprosy	0.00134	0.0133	CcSEcCtD
Toremifene—Angina pectoris—Thalidomide—leprosy	0.0013	0.0129	CcSEcCtD
Toremifene—Weight increased—Thalidomide—leprosy	0.00122	0.0121	CcSEcCtD
Toremifene—Acute coronary syndrome—Thalidomide—leprosy	0.00118	0.0117	CcSEcCtD
Toremifene—Myocardial infarction—Thalidomide—leprosy	0.00117	0.0116	CcSEcCtD
Toremifene—Neuropathy peripheral—Thalidomide—leprosy	0.00117	0.0116	CcSEcCtD
Toremifene—Sweating—Thalidomide—leprosy	0.00114	0.0113	CcSEcCtD
Toremifene—Visual impairment—Thalidomide—leprosy	0.00103	0.0102	CcSEcCtD
Toremifene—Eye disorder—Thalidomide—leprosy	0.001	0.00993	CcSEcCtD
Toremifene—Angiopathy—Thalidomide—leprosy	0.000971	0.00964	CcSEcCtD
Toremifene—Mediastinal disorder—Thalidomide—leprosy	0.000965	0.00957	CcSEcCtD
Toremifene—Chills—Thalidomide—leprosy	0.000961	0.00953	CcSEcCtD
Toremifene—Arrhythmia—Thalidomide—leprosy	0.000956	0.00949	CcSEcCtD
Toremifene—Alopecia—Thalidomide—leprosy	0.000946	0.00939	CcSEcCtD
Toremifene—Vomiting—Dapsone—leprosy	0.000945	0.00937	CcSEcCtD
Toremifene—Mental disorder—Thalidomide—leprosy	0.000938	0.00931	CcSEcCtD
Toremifene—Malnutrition—Thalidomide—leprosy	0.000932	0.00925	CcSEcCtD
Toremifene—Headache—Dapsone—leprosy	0.000931	0.00924	CcSEcCtD
Toremifene—Back pain—Thalidomide—leprosy	0.000901	0.00895	CcSEcCtD
Toremifene—Nausea—Dapsone—leprosy	0.000883	0.00876	CcSEcCtD
Toremifene—Vision blurred—Thalidomide—leprosy	0.000878	0.00872	CcSEcCtD
Toremifene—Tremor—Thalidomide—leprosy	0.000873	0.00866	CcSEcCtD
Toremifene—Vertigo—Thalidomide—leprosy	0.000837	0.00831	CcSEcCtD
Toremifene—Leukopenia—Thalidomide—leprosy	0.000834	0.00828	CcSEcCtD
Toremifene—Chest pain—Thalidomide—leprosy	0.000793	0.00787	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000788	0.00782	CcSEcCtD
Toremifene—Oedema—Thalidomide—leprosy	0.000761	0.00755	CcSEcCtD
Toremifene—Nervous system disorder—Thalidomide—leprosy	0.000746	0.0074	CcSEcCtD
Toremifene—Thrombocytopenia—Thalidomide—leprosy	0.000745	0.00739	CcSEcCtD
Toremifene—Skin disorder—Thalidomide—leprosy	0.000739	0.00733	CcSEcCtD
Toremifene—Hyperhidrosis—Thalidomide—leprosy	0.000735	0.0073	CcSEcCtD
Toremifene—Anorexia—Thalidomide—leprosy	0.000725	0.00719	CcSEcCtD
Toremifene—Insomnia—Thalidomide—leprosy	0.000688	0.00683	CcSEcCtD
Toremifene—Dyspnoea—Thalidomide—leprosy	0.000678	0.00673	CcSEcCtD
Toremifene—Decreased appetite—Thalidomide—leprosy	0.000661	0.00656	CcSEcCtD
Toremifene—Gastrointestinal disorder—Thalidomide—leprosy	0.000657	0.00652	CcSEcCtD
Toremifene—Fatigue—Thalidomide—leprosy	0.000656	0.00651	CcSEcCtD
Toremifene—Pain—Thalidomide—leprosy	0.00065	0.00645	CcSEcCtD
Toremifene—Constipation—Thalidomide—leprosy	0.00065	0.00645	CcSEcCtD
Toremifene—Asthenia—Thalidomide—leprosy	0.000546	0.00542	CcSEcCtD
Toremifene—Pruritus—Thalidomide—leprosy	0.000538	0.00534	CcSEcCtD
Toremifene—Dizziness—Thalidomide—leprosy	0.000503	0.00499	CcSEcCtD
Toremifene—Vomiting—Thalidomide—leprosy	0.000484	0.0048	CcSEcCtD
Toremifene—Rash—Thalidomide—leprosy	0.00048	0.00476	CcSEcCtD
Toremifene—Dermatitis—Thalidomide—leprosy	0.000479	0.00475	CcSEcCtD
Toremifene—Headache—Thalidomide—leprosy	0.000476	0.00473	CcSEcCtD
Toremifene—Nausea—Thalidomide—leprosy	0.000452	0.00448	CcSEcCtD
